Company: VCYT
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001384101-25-000060
Chunk: 15

Company: VERACYTE, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
ACYTE, INC.

 Condensed Consolidated Statements of Comprehensive Income (Loss)

 (Unaudited)

 (In thousands)

 Three Months Ended March 31, 20252024Net income (loss)$7,047 $(1,864)Other comprehensive income (loss):Change in currency translation adjustments7,449 (4,889)Net comprehensive income (loss)$14,496 $(6,753)

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

VERACYTE, INC.

Condensed Consolidated Statements of Stockholders' Equity

(Unaudited)

(In thousands)

 Common StockAdditionalPaid-inCapitalAccumulated DeficitAccumulated Other Comprehensive LossTotalStockholders'Equity SharesAmountBalance at December 31, 202477,773 $78 $1,655,961 $(443,983)$(36,090)$1,175,966 Issuance of common stock on exercise of stock options and vesting of restricted stock units449 — 1,320 — — 1,320 Issuance of common stock under employee stock purchase plan (ESPP)84 — 1,647 — — 1,647 Tax portion of vested restricted stock units— — (9,451)— — (9,451)Stock-based compensation expense (employee)— — 10,753 — — 10,753 Stock-based compensation expense (ESPP)— — 205 — — 205 Net income— — — 7,047 — 7,047 Other comprehensive income— — — — 7,449 7,449 Balance at March 31, 202578,306 $78 $1,660,435 $(436,936)$(28,641)$1,194,936 

 Common StockAdditionalPaid-inCapitalAccumulated DeficitAccumulated Other Comprehensive LossTotalStockholders'Equity SharesAmountBalance at December 31, 202373,265 $73 $1,536,168 $(468,121)$(24,018)$1,044,102 Issuance of common stock and options for acquisition2,698 3 74,142 — — 74,145 Issuance of common stock on exercise of stock options and vesting of restricted stock units382